LUCERNA: A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer (clinicaltrials.gov) - Sep 15, 2026 - P3 | N=500 | Recruiting | Sponsor: Astellas Pharma Global Development, Inc. | Trial completion date: Mar 2027 ➔ Sep 2028 | Trial primary completion date: Mar 2027 ➔ Sep 2028
Trial completion date • Trial primary completion date • Esophageal Cancer • Gastric Adenocarcinoma • Gastric Cancer • Gastroesophageal Junction Adenocarcinoma • Oncology • Solid Tumor • CLDN18 • HER-2 • MSI • PD-L1
|